Physician profile
Neil S Mcdevitt
NPI 1649242447
$7,874.78
in general payments reported to CMS, 2019-2025
20 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,284 · 2020: $46.12 · 2021: $12.67 · 2022: $114 · 2023: $185 · 2024: $58.60 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $418.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,032.98 | 2019-2024 | |
| Medtronic, INC. | $143.83 | 2022-2024 | Endoflip, Signia |
| Intra-Sana Laboratories | $134.09 | 2024-2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Siemens Medical Solutions USA, INC. | $109.70 | 2019 | |
| Davol INC. | $89.00 | 2022-2025 | Phasix Mesh |
| Ethicon US, LLC | $62.56 | 2019 | |
| Aroa Biosurgery Incorporated | $39.58 | 2022-2023 | |
| Endo Pharmaceuticals INC. | $39.20 | 2019-2020 | |
| Shire North American Group INC | $34.31 | 2019 | |
| Novo Nordisk INC | $29.60 | 2019-2022 | |
| Tela Bio, INC. | $23.42 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Heron Therapeutics, INC. | $19.71 | 2024 | Aponvie |
| W. L. Gore & Associates, INC. | $17.11 | 2022 | |
| Integra Lifesciences Corporation | $17.05 | 2020 | |
| Kci USA, INC. | $16.86 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $13.93 | 2023 | Weck |
| Cook Medical LLC | $13.51 | 2019 | |
| Medtronic Vascular, INC. | $13.27 | 2020 | |
| Olympus America INC. | $12.67 | 2021 | |
| Ambu INC. | $12.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Mcdevitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.